Our Team
Leadership & Executive Committee
LAUREN LEIMAN
Executive Director, BLOODPAC Consortium
PHILLIP G. FEBBO, MD
Chief Scientific Officer & Chief Medical Officer, Veracyte
ROBERT L. GROSSMAN, PhD
Professor, University of Chicago
CTDS & Founder/Director, Open Commons Consortium
PETER KUHN, PhD
Professor, University of Southern California
NANCY KRUNIC, PhD
Vice President and Precision Medicine Head, Diagnostic Sciences & Partnerships, Novartis
JAKE VINSON
Chief Executive Officer, Prostate Cancer Clinical Trials Consortium
Scientific Co-Chair Committee
JONATHAN BADEN
Executive Director, Head of Solid Tumor Oncology Diagnostics, Bristol Meyers Squibb
KELLI BRAMLETT
Committee Chair
Executive Director, R&D, Molecular Oncology, Quest Diagnostics
DARYA CHUDOVA, PhD
Chief Technology Officer, Guardant Health
JIM GODSEY, PhD
Chief Scientific Officer and VP of R&D, Molecular Genomics & Oncology, Quest Diagnostics
JENNIFER DICKEY, PhD
Vice President, Regulatory and Quality, Personal Genome Diagnostics
JERRY LEE, PhD
Chief Science and Innovation Officer, Ellison Institute of Technology
TRACI PAWLOWSKI, PhD
Vice President and Head Clinical Solutions, Illumina
ELIZABETH MANSFIELD, PhD
Vice President of Regulatory Policy, Foundation Medicine, Inc.
HOWARD SCHER, MD
Physician and Head, Biomarker Development Initiative, Memorial Sloan Kettering Cancer Center
ANGELA SILVESTRO
Director, Companion Diagnostics, GSK
JOHN SIMMONS
Global Vice President of Biopharma, Natera
BLOODPAC Team
ROBERT L. GROSSMAN, PhD
Professor, University of Chicago CTDS & Founder/Director, Open Commons Consortium
CHEYENNE JANKIEWICZ
Program Manager / Data Coordinator, BLOODPAC
DANNE C. ELBERS, PhD
Director of Data Science, BLOODPAC
DORYS LOPEZ, PhD
Head of Scientific Communications, BLOODPAC
GINGER RIESSEN, CPA
Accountant, BLOODPAC
LAURA TRAMONTOZZI
Brand + Design, BLOODPAC